知镜 Cognispect · 医学文献与研究工作台

Anemia and Patient-Reported Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real-World Observational Study.

Oliva EN, Risitano AM, Bona ED, Vannucchi AM, Dellfino IM, De Vivo A, Giai V, Notaro R, Iannì G, Beggiato E, Sica S, La Barba G, Balakrishnan S, Large J, Thavarajah T, Raso S, Fontana R, Barcellini W, Fattizzo B, Trikha R, Marano L, Panse J, Kulasekararaj AG.
EJHaem · 2026-08-11 · PMID 42583311

文献摘要

Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder characterized by complement-mediated hemolysis, thrombosis, bone marrow failure, and anemia. Although current treatments improve outcomes, patients still experience hemolysis and could remain anemic with a negative impact on quality of life (QoL). The aim of this study was to assess whether patient-reported outcomes (PROs) distinguish PNH patients with/without hemolysis and evaluate factors associated with PROs. Methods In this international, multicenter, observational study, 97 PNH patients witfrom Italy and the UK completed the EORTC QLQ-C30 and QLQ-AA/PNH measures at baseline and after 2 weeks. Clinical, biochemical, and treatment data were collected. Hemolysis was defined as LDH ≥ 1.5 × upper normal limit. PRO scores were compared between patients above and below this threshold. Associations of PROs with patient and disease factors were analyzed. Results Of 97 patients (mean age 49 ± 15), 24.7% were anemic (Hb p α > 0.7) and test-retest reliability (ICC: 0.72-0.95). Conclusions Anemia, but not residual hemolysis, was associated with impaired QoL across multiple domains. Addressing anemia alongside hemolysis may improve PROs in the management of PNH. Trial registration The authors have confirmed clinical trial registration is not needed for this submission.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。